Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 567

1.

Increased type 2 inflammation post rhinovirus infection in patients with moderate asthma.

Southworth T, Pattwell C, Khan N, Mowbray SF, Strieter RM, Erpenbeck VJ, Singh D.

Cytokine. 2019 Sep 23;125:154857. doi: 10.1016/j.cyto.2019.154857. [Epub ahead of print]

PMID:
31557636
2.

Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease.

Mehrad B, Burdick MD, Wandersee NJ, Shahir KS, Zhang L, Simpson PM, Strieter RM, Field JJ.

Blood Adv. 2017 Nov 6;1(24):2217-2224. doi: 10.1182/bloodadvances.2017010777. eCollection 2017 Nov 14.

3.

Circulating fibrocytes as predictors of adverse events in unstable angina.

Keeley EC, Schutt RC, Marinescu MA, Burdick MD, Strieter RM, Mehrad B.

Transl Res. 2016 Jun;172:73-83.e1. doi: 10.1016/j.trsl.2016.02.013. Epub 2016 Mar 8.

4.

Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity.

Shipe R, Burdick MD, Strieter BA, Liu L, Shim YM, Sung SS, Teague WG, Mehrad B, Strieter RM, Rose CE Jr.

J Allergy Clin Immunol. 2016 Mar;137(3):750-7.e3. doi: 10.1016/j.jaci.2015.07.037. Epub 2015 Sep 12.

5.

GITR agonist enhances vaccination responses in lung cancer.

Zhu LX, Davoodi M, Srivastava MK, Kachroo P, Lee JM, St John M, Harris-White M, Huang M, Strieter RM, Dubinett S, Sharma S.

Oncoimmunology. 2015 Apr 27;4(4):e992237. eCollection 2015 Apr.

6.

Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia.

Karafin MS, Dogra S, Rodeghier M, Burdick M, Mehrad B, Rose CE, Strieter RM, DeBaun MR, Strunk RC, Field JJ.

Pediatr Pulmonol. 2016 Mar;51(3):295-9. doi: 10.1002/ppul.23248. Epub 2015 Jun 30.

7.

Drug development for airway diseases: looking forward.

Holgate S, Agusti A, Strieter RM, Anderson GP, Fogel R, Bel E, Martin TR, Reiss TF.

Nat Rev Drug Discov. 2015 Jun;14(6):367-8. doi: 10.1038/nrd4645. Epub 2015 May 22.

PMID:
26000726
8.

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

Ilkow CS, Marguerie M, Batenchuk C, Mayer J, Ben Neriah D, Cousineau S, Falls T, Jennings VA, Boileau M, Bellamy D, Bastin D, de Souza CT, Alkayyal A, Zhang J, Le Boeuf F, Arulanandam R, Stubbert L, Sampath P, Thorne SH, Paramanthan P, Chatterjee A, Strieter RM, Burdick M, Addison CL, Stojdl DF, Atkins HL, Auer RC, Diallo JS, Lichty BD, Bell JC.

Nat Med. 2015 May;21(5):530-6. doi: 10.1038/nm.3848. Epub 2015 Apr 20.

PMID:
25894825
9.

A critical role of CXCR2 PDZ-mediated interactions in endothelial progenitor cell homing and angiogenesis.

Hou Y, Wu Y, Farooq SM, Guan X, Wang S, Liu Y, Oblak JJ, Holcomb J, Jiang Y, Strieter RM, Lasley RD, Arbab AS, Sun F, Li C, Yang Z.

Stem Cell Res. 2015 Mar;14(2):133-43. doi: 10.1016/j.scr.2014.12.001. Epub 2014 Dec 30.

10.

Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome.

Trimble A, Gochuico BR, Markello TC, Fischer R, Gahl WA, Lee JK, Kim Y, Burdick MD, Strieter RM, Mehrad B.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1395-401. doi: 10.1164/rccm.201407-1287OC.

11.

Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.

Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I, Nadeau K, Kaiser S, Peters T, Perez A, Jones I, Arm JP, Strieter RM, Sabo R, Gunawardena KA.

J Allergy Clin Immunol. 2015 Feb;135(2):500-7. doi: 10.1016/j.jaci.2014.07.049. Epub 2014 Sep 13.

PMID:
25226850
12.

CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.

Choi YH, Burdick MD, Strieter BA, Mehrad B, Strieter RM.

Mol Cancer Res. 2014 Jan;12(1):38-47. doi: 10.1158/1541-7786.MCR-12-0334. Epub 2013 Sep 11.

13.

Dose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia.

Camnitz W, Burdick MD, Strieter RM, Mehrad B, Keeley EC.

Clin Transl Med. 2012 Oct 6;1(1):23. doi: 10.1186/2001-1326-1-23.

14.

CCL21 Chemokine Therapy for Lung Cancer.

Sharma S, Zhu L, Srivastava MK, Harris-White M, Huang M, Lee JM, Rosen F, Lee G, Wang G, Kickhoefer V, Rome LH, Baratelli F, St John M, Reckamp K, Chul-Yang S, Hillinger S, Strieter R, Dubinett S.

Int Trends Immun. 2013 Jan;1(1):10-15.

15.

Fibrocytes and the pathogenesis of diffuse parenchymal lung disease.

Mehrad B, Strieter RM.

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S22. doi: 10.1186/1755-1536-5-S1-S22. eCollection 2012.

16.

Plasma CXCL12 levels as a predictor of future stroke.

Schutt RC, Burdick MD, Strieter RM, Mehrad B, Keeley EC.

Stroke. 2012 Dec;43(12):3382-6. doi: 10.1161/STROKEAHA.112.660878. Epub 2012 Oct 4.

17.

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.

Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S.

Immunotargets Ther. 2012 Oct 1;2012(1):7-12.

18.

Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.

Cripps JG, Celaj S, Burdick M, Strieter RM, Gorham JD.

Lab Invest. 2012 Oct;92(10):1461-71. doi: 10.1038/labinvest.2012.104. Epub 2012 Aug 20.

19.

Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Srivastava MK, Zhu L, Harris-White M, Kar UK, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S.

PLoS One. 2012;7(7):e40677. doi: 10.1371/journal.pone.0040677. Epub 2012 Jul 16. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/5c756e7d-6e97-416f-836a-dced97cf46af. Kar, Upendra [corrected to Kar, Upendra K].

20.

Elevated circulating fibrocyte levels in patients with hypertensive heart disease.

Keeley EC, Mehrad B, Janardhanan R, Salerno M, Hunter JR, Burdick MM, Field JJ, Strieter RM, Kramer CM.

J Hypertens. 2012 Sep;30(9):1856-61. doi: 10.1097/HJH.0b013e32835639bb.

21.

Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension.

Ross DJ, Strieter RM, Fishbein MC, Ardehali A, Belperio JA.

J Heart Lung Transplant. 2012 Aug;31(8):865-73. doi: 10.1016/j.healun.2012.04.008. Epub 2012 May 30.

PMID:
22658713
22.

The role of fibrocytes in sickle cell lung disease.

Field JJ, Burdick MD, DeBaun MR, Strieter BA, Liu L, Mehrad B, Rose CE Jr, Linden J, Strieter RM.

PLoS One. 2012;7(3):e33702. doi: 10.1371/journal.pone.0033702. Epub 2012 Mar 19.

23.

Adenosine A2B receptor blockade slows growth of bladder and breast tumors.

Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J.

J Immunol. 2012 Jan 1;188(1):198-205. doi: 10.4049/jimmunol.1101845. Epub 2011 Nov 23.

24.

Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis.

Crawford MA, Lowe DE, Fisher DJ, Stibitz S, Plaut RD, Beaber JW, Zemansky J, Mehrad B, Glomski IJ, Strieter RM, Hughes MA.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17159-64. doi: 10.1073/pnas.1108495108. Epub 2011 Sep 26.

25.

Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.

LaPar DJ, Burdick MD, Emaminia A, Harris DA, Strieter BA, Liu L, Robbins M, Kron IL, Strieter RM, Lau CL.

Ann Thorac Surg. 2011 Aug;92(2):470-7; discussion 477. doi: 10.1016/j.athoracsur.2011.04.065.

26.

Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease.

Keeley EC, Moorman JR, Liu L, Gimple LW, Lipson LC, Ragosta M, Taylor AM, Lake DE, Burdick MD, Mehrad B, Strieter RM.

PLoS One. 2011;6(6):e21174. doi: 10.1371/journal.pone.0021174. Epub 2011 Jun 22.

27.

Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling.

Delano MJ, Kelly-Scumpia KM, Thayer TC, Winfield RD, Scumpia PO, Cuenca AG, Harrington PB, O'Malley KA, Warner E, Gabrilovich S, Mathews CE, Laface D, Heyworth PG, Ramphal R, Strieter RM, Moldawer LL, Efron PA.

J Immunol. 2011 Jul 15;187(2):911-8. doi: 10.4049/jimmunol.1100588. Epub 2011 Jun 20.

28.

Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.

Andersson A, Srivastava MK, Harris-White M, Huang M, Zhu L, Elashoff D, Strieter RM, Dubinett SM, Sharma S.

Clin Cancer Res. 2011 Jun 1;17(11):3660-72. doi: 10.1158/1078-0432.CCR-10-3346.

29.

Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Palchevskiy V, Hashemi N, Weigt SS, Xue YY, Derhovanessian A, Keane MP, Strieter RM, Fishbein MC, Deng JC, Lynch JP 3rd, Elashoff R, Belperio JA.

Fibrogenesis Tissue Repair. 2011 Apr 4;4:10. doi: 10.1186/1755-1536-4-10.

30.

Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.

Li A, King J, Moro A, Sugi MD, Dawson DW, Kaplan J, Li G, Lu X, Strieter RM, Burdick M, Go VL, Reber HA, Eibl G, Hines OJ.

Am J Pathol. 2011 Mar;178(3):1340-9. doi: 10.1016/j.ajpath.2010.11.058.

31.

The role of fibrocytes in fibrotic diseases of the lungs and heart.

Keeley EC, Mehrad B, Strieter RM.

Fibrogenesis Tissue Repair. 2011 Jan 10;4:2. doi: 10.1186/1755-1536-4-2.

32.

Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.

Crawford MA, Burdick MD, Glomski IJ, Boyer AE, Barr JR, Mehrad B, Strieter RM, Hughes MA.

PLoS Pathog. 2010 Nov 18;6(11):e1001199. doi: 10.1371/journal.ppat.1001199.

33.

Chemokines as mediators of tumor angiogenesis and neovascularization.

Keeley EC, Mehrad B, Strieter RM.

Exp Cell Res. 2011 Mar 10;317(5):685-90. doi: 10.1016/j.yexcr.2010.10.020. Epub 2010 Oct 30. Review.

34.

Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.

Struyf S, Salogni L, Burdick MD, Vandercappellen J, Gouwy M, Noppen S, Proost P, Opdenakker G, Parmentier M, Gerard C, Sozzani S, Strieter RM, Van Damme J.

Blood. 2011 Jan 13;117(2):480-8. doi: 10.1182/blood-2009-11-253591. Epub 2010 Oct 27.

35.

Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.

Dengel LT, Norrod AG, Gregory BL, Clancy-Thompson E, Burdick MD, Strieter RM, Slingluff CL Jr, Mullins DW.

J Immunother. 2010 Nov-Dec;33(9):965-74. doi: 10.1097/CJI.0b013e3181fb045d.

36.

Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop.

Park SJ, Burdick MD, Brix WK, Stoler MH, Askew DS, Strieter RM, Mehrad B.

J Immunol. 2010 Nov 15;185(10):6190-7. doi: 10.4049/jimmunol.1002064. Epub 2010 Oct 6.

37.

Role of LTBâ‚„ in the pathogenesis of elastase-induced murine pulmonary emphysema.

Shim YM, Paige M, Hanna H, Kim SH, Burdick MD, Strieter RM.

Am J Physiol Lung Cell Mol Physiol. 2010 Dec;299(6):L749-59. doi: 10.1152/ajplung.00116.2010. Epub 2010 Sep 3.

38.

V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy.

Ajuebor MN, Chen Q, Strieter RM, Adegboyega PA, Aw TY.

J Virol. 2010 Sep;84(17):8520-9. doi: 10.1128/JVI.00605-10. Epub 2010 Jun 23.

39.

Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis.

Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11068-73. doi: 10.1073/pnas.1006375107. Epub 2010 Jun 1.

40.

CXC chemokines in cancer angiogenesis and metastases.

Keeley EC, Mehrad B, Strieter RM.

Adv Cancer Res. 2010;106:91-111. doi: 10.1016/S0065-230X(10)06003-3. Review.

41.

An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells.

Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, van Rooijen N, Chaconas G, Kubes P.

Nat Immunol. 2010 Apr;11(4):295-302. doi: 10.1038/ni.1855. Epub 2010 Mar 14.

42.

Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza.

Zavitz CC, Bauer CM, Gaschler GJ, Fraser KM, Strieter RM, Hogaboam CM, Stampfli MR.

J Immunol. 2010 Feb 15;184(4):2001-13. doi: 10.4049/jimmunol.0903304. Epub 2010 Jan 11.

43.

IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury.

Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD.

J Clin Invest. 2010 Jan;120(1):331-42. doi: 10.1172/JCI38702. Epub 2009 Dec 14.

44.

Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes.

Choi YH, Burdick MD, Strieter RM.

Int J Biochem Cell Biol. 2010 May;42(5):662-71. doi: 10.1016/j.biocel.2009.12.011. Epub 2009 Dec 23.

45.

New mechanisms of pulmonary fibrosis.

Strieter RM, Mehrad B.

Chest. 2009 Nov;136(5):1364-1370. doi: 10.1378/chest.09-0510. Review.

46.

Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma.

Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, Magyar CE, Dohadwala M, Lee JM, St John MA, Strieter RM, Sharma S, Dubinett SM.

Clin Cancer Res. 2009 Nov 15;15(22):6820-9. doi: 10.1158/1078-0432.CCR-09-1558. Epub 2009 Nov 3.

47.

Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.

Keeley EC, Mehrad B, Strieter RM.

Int J Biochem Cell Biol. 2010 Apr;42(4):535-42. doi: 10.1016/j.biocel.2009.10.014. Epub 2009 Oct 20. Review.

48.

The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.

Strieter RM, Keeley EC, Burdick MD, Mehrad B.

Trans Am Clin Climatol Assoc. 2009;120:49-59. Review.

49.

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis.

Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B.

J Leukoc Biol. 2009 Nov;86(5):1111-8. doi: 10.1189/jlb.0309132. Epub 2009 Jul 6. Review.

50.

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.

Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM.

BMC Cancer. 2009 Jun 29;9:213. doi: 10.1186/1471-2407-9-213.

Supplemental Content

Loading ...
Support Center